Exploring the ethics of genetic prioritisation for COVID-19 vaccines

Bruce and Johnson outline known genetic risk factors for COVID-19 and consider the potential role of genomics in vaccine allocation policies. The authors argue in favor of schemes that protect people who are genetically vulnerable to severe disease.